Atlas Trials

Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor

Clinical trial NCT02639650 · UNKNOWN

Trial details

NCT number
NCT02639650
Sponsor
Weiguo Lv
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Gestational Trophoblastic Neoplasms
Start date
2016-03-01
Primary completion
2024-03-01
Enrollment
214

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.